España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
IDEXX Laboratories
IDXX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$413.62
0.46
0.11%
At close: -
$415.00
1.38
0.33%
After Hours: Dec 24, 3:59 PM EDT
Get Report
Comment
IDEXX Laboratories (IDXX) Forecast
News
Earnings
IDEXX Laboratories (IDXX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for IDEXX Laboratories (NASDAQ:IDXX) Stock
IDEXX Laboratories Stock (NASDAQ: IDXX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, December 22, 2024
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Vandana Singh
Monday, December 09, 2024
(IDXX) - Analyzing IDEXX Laboratories's Short Interest
Benzinga Insights
IDEXX Laboratories Board Authorizes Increase ...
Benzinga Newsdesk
Monday, December 02, 2024
A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts
Benzinga Insights
Leerink Partners Initiates Coverage On IDEXX ...
Benzinga Newsdesk
Thursday, November 21, 2024
IDEXX Names Andrew Emerson To Serve As Next C...
Benzinga Newsdesk
Monday, November 04, 2024
Decoding 5 Analyst Evaluations For IDEXX Laboratories
Benzinga Insights
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,600 Today
Benzinga Insights
Piper Sandler Reiterates Neutral on IDEXX Lab...
Benzinga Newsdesk
Barclays Maintains Overweight on IDEXX Labora...
Benzinga Newsdesk
Thursday, October 31, 2024
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
Vandana Singh
IDEXX Laboratories shares are trading lower a...
Benzinga Newsdesk
IDEXX Laboratories Expects 2024 Adjusted EPS ...
Benzinga Newsdesk
IDEXX Laboratories Expects 2024 Revenue Of $3...
Benzinga Newsdesk
IDEXX Laboratories Q3 2024 Adj EPS $2.79 Beat...
Benzinga Newsdesk
Friday, October 11, 2024
What Analysts Are Saying About IDEXX Laboratories Stock
Benzinga Insights
JP Morgan Maintains Overweight on IDEXX Labor...
Benzinga Newsdesk
Thursday, October 10, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,000 Today
Benzinga Insights
Stifel Maintains Hold on IDEXX Laboratories, ...
Benzinga Newsdesk
Friday, September 27, 2024
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years
Benzinga Insights
Tuesday, September 10, 2024
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years
Benzinga Insights
Massive Insider Trade At IDEXX Laboratories
Benzinga Insights
Monday, August 19, 2024
$100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today
Benzinga Insights
Friday, August 16, 2024
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
Benzinga Insights
Wednesday, August 14, 2024
Piper Sandler Maintains Neutral on IDEXX Labo...
Benzinga Newsdesk
Tuesday, August 06, 2024
IDEXX Q2 Earnings Miss Estimates, 2024 View Down
Zacks
Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst
Vandana Singh
IDEXX Laboratories shares are trading higher ...
Benzinga Newsdesk
IDEXX Laboratories Expects 2024 Adjusted EPS ...
Benzinga Newsdesk
IDEXX Laboratories Expects 2024 Revenue Of $3...
Benzinga Newsdesk
IDEXX Laboratories Q2 2024 Adj. EPS $3.02 Bea...
Benzinga Newsdesk
Monday, August 05, 2024
What's in Store for These 3 MedTech Stocks in Q2 Earnings?
Zacks
Thursday, July 25, 2024
Analyst Ratings For IDEXX Laboratories
Benzinga Insights
BTIG Initiates Coverage On IDEXX Laboratories...
Benzinga Newsdesk
Thursday, July 18, 2024
Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today
Benzinga Insights
Thursday, July 11, 2024
P/E Ratio Insights for IDEXX Laboratories
Benzinga Insights
Tuesday, July 09, 2024
Looking Into IDEXX Laboratories's Recent Short Interest
Benzinga Insights
Friday, July 05, 2024
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Benzinga Insights
Monday, June 24, 2024
Stifel Maintains Hold on IDEXX Laboratories, ...
Benzinga Newsdesk
Tuesday, June 18, 2024
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,600 Today
Benzinga Insights
Thursday, June 13, 2024
How Is The Market Feeling About IDEXX Laboratories?
Benzinga Insights
Tuesday, June 04, 2024
Idexx Laboratories Has Launched Catalyst Panc...
Benzinga Newsdesk
Thursday, May 30, 2024
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,500 Today
Benzinga Insights
Monday, May 20, 2024
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,500 Today
Benzinga Insights
Wednesday, May 15, 2024
S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally
Piero Cingari
Tuesday, May 14, 2024
Morgan Stanley Maintains Overweight on IDEXX ...
Benzinga Newsdesk
Thursday, May 09, 2024
Sam Samad Sees Potential Growth And Acquires In IDEXX Laboratories Stock Options
Benzinga Insights
Insider Activity Spotlight: Bruce L Claflin Acquires In IDEXX Laboratories Stock Options
Benzinga Insights
Thursday, May 02, 2024
Barclays Maintains Overweight on IDEXX Labora...
Benzinga Newsdesk
Wednesday, May 01, 2024
Aging Pet Population Is 'Solid Longer-Term Tailwind' For IDEXX Labs: Analyst
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch